Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ATN-224
DRUG
2 trials
Sponsors
Attenuon
Conditions
Melanoma
Prostate Cancer
Phase 2
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
NCT00383851
Attenuon
Melanoma
Start: 2006-09-30
End: 2008-09-30
Target: 60
Updated: 2007-12-06
Study of ATN-224 in Patients With Prostate Cancer
NCT00405574
Attenuon
Prostate Cancer
Start: 2006-11-30
End: 2008-09-30
Target: 50
Updated: 2008-01-30